
taken off the market. Merck has already settled thousands of lawsuits in the US over the effects of Vioxx for $US4.85 billion, but has made no admission of guilt. The company is fighting the class action in Austral...

prices. Other drugs failed at a very late stage of development due to serious side effects, and, once on the market such as Vioxx, at a loss of hundreds of millions of dollars. Janet Woodcook, the FDA's deputy commi...

like bleeding and ulcers. So the new class of COX-2 inhibitors, like Vioxx, were supposed to stop the pain without the nasty stomach side-effects. Of course, aspirin has the additional side effect of protecting your...

painkillers on a long-term basis. The study shows that around the time Vioxx was withdrawn from the market, the rate of GI side effects went up again. Q: What are patients with chronic pain doing now without these...

around 90,000 - 140,000. (1) The salient point here is that these deaths were not merely "side effects" of Vioxx. The fact that Vioxx was so effective at suppressing arthritic conditions is the very same reason why...

to Vioxx. "However, our findings suggest an increased risk" of dangerous cardiovascular side effects for Vioxx patients compared with placebo recipients, they say. There was no significant difference in heart-relat...

6:14 pm ET Peter Benesh Vioxx is turning into the story that won't go away. At the same time that Merck's (NYSE:MRK - News) first payments are going out to people affected by side effects from the anti-inflammatory...

Vioxx was a blockbuster drug. Launched by Merck & Co., Inc., in 1999 as a treatment for painful arthritis , its annual sales soon reached $2 billion. The benefits were much the same as other anti-inflammatory...

heart attack in order to have their arthritic pain relieved without other side-effects The blockbuster anti-athritis drug Vioxx doubled the risk of heart attacks and was not fit to be on the market for arthritis...

with Vioxx, a blockbuster pain drug the FDA approved in 1999, only to pull... to give the bulk of its decision-making power to scientists who approve new drugs, rather than those who monitor the side effects of ...